Eaton Vance Management Exact Sciences Corp Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Eaton Vance Management holds 222,122 shares of EXAS stock, worth $9.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
222,122
Previous 221,168
0.43%
Holding current value
$9.42 Million
Previous $8.71 Million
17.16%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding EXAS
# of Institutions
699Shares Held
160MCall Options Held
5.84MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$753 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$553 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$525 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$483 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$453 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.51B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...